Transcriptomic analyses and experimental verification reveal potential biomarkers and biological pathways of urinary tract infection

References

• Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566.
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284.
   PubMed Web of Science ®Google Scholar
• McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11):946–957.
   PubMed Web of Science ®Google Scholar
• Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85(1):11–19.
   PubMed Web of Science ®Google Scholar
• Mantione KJ, Kream RM, Kuzelova H, et al. Comparing bioinformatic gene expression profiling methods: microarray and RNA-Seq. Med Sci Monit Basic Res. 2014;20:138–142.
   PubMedGoogle Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41( Database issue):D991–5.
   PubMed Web of Science ®Google Scholar
• Lutay N, Ambite I, Grönberg Hernandez J, et al. Bacterial control of host gene expression through RNA polymerase II. J Clin Invest. 2013;123(6):2366–2379.
   PubMed Web of Science ®Google Scholar
• Klarström Engström K, Zhang B, Demirel I. Human renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli. Sci Rep. 2019;9(1):2296.
   PubMed Web of Science ®Google Scholar
• Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846–1847.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;4(Suppl 4):S11. 8 Suppl.
   Web of Science ®Google Scholar
• Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13.
   PubMed Web of Science ®Google Scholar
• Barber AE, Norton JP, Wiles TJ, et al. Strengths and limitations of model systems for the study of urinary tract infections and related pathologies. Microbiol Mol Biol Rev. 2016;80(2):351–367.
   PubMed Web of Science ®Google Scholar
• Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer. J Am Board Fam Pract. 2000;13(6):392–397.
   PubMedGoogle Scholar
• Sundén F, Butler D, Wullt B. Triggered urine interleukin-6 correlates to severity of symptoms in nonfebrile lower urinary tract infections. J Urol. 2017;198(1):107–115.
   PubMed Web of Science ®Google Scholar
• Al Rushood M, Al-Eisa A, Al-Attiyah R. Serum and urine interleukin-6 and interleukin-8 levels do not differentiate acute pyelonephritis from lower urinary tract infections in children. J Inflamm Res. 2020;13:789–797.
   PubMed Web of Science ®Google Scholar
• Engelsöy U, Rangel I, Demirel I. Impact of proinflammatory cytokines on the virulence of uropathogenic escherichia coli. Front Microbiol. 2019;10:1051.
   PubMed Web of Science ®Google Scholar
• Demirel I, Persson A, Brauner A, et al. Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils. Sci Rep. 2020;10(1):21837.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mémet S, Saban R, et al. Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli. Sci Rep. 2015;5(1):16234.
   PubMed Web of Science ®Google Scholar
• Song J, Duncan MJ, Li G, et al. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 2007;3(4):e60.
   PubMed Web of Science ®Google Scholar
• Bottek J, Soun C, Lill JK, et al. Spatial proteomics revealed a CX(3) CL1-dependentcrosstalk between the urothelium and relocated macrophages through IL-6 during an acute bacterial infection in the urinary bladder. Mucosal Immunol. 2020;13(4):702–714.
   PubMed Web of Science ®Google Scholar
• Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006;71(8):1206–1218.
   PubMed Web of Science ®Google Scholar
• Erman A, Lakota K, Mrak-Poljsak K, et al. Uropathogenic Escherichia coli induces serum amyloid a in mice following urinary tract and systemic inoculation. PLoS One. 2012;7(3):e32933.
   PubMed Web of Science ®Google Scholar
• Armbruster CE, Smith SN, Mody L, et al. Urine cytokine and chemokine levels predict urinary tract infection severity independent of uropathogen, urine bacterial burden, host genetics, and host age. Infect Immun. 2018;86(9):9.
   Web of Science ®Google Scholar
• Yeh J, Lu M, Alvarez-Lugo L, et al. Bladder urothelial BK channel activity is a critical mediator for innate immune response in urinary tract infection pathogenesis. Am J Physiol Renal Physiol. 2019;316(4):F617–F623.
   PubMed Web of Science ®Google Scholar